David Beckham Partners with Prenetics

  • ⁠Beckham becomes a strategic investor in Prenetics
  • ⁠⁠Beckham and Prenetics are co-founding partners for IM8, a new health and wellness brand
Thank you! Your submission has been received!
Sorry, there was an error while submitting the form.

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health.

Prevention

At CircleDNA, we recognize that every individual has unique health needs and goals, and we are dedicated to empowering them with the tools and knowledge to take control of their health.

Early Detection

Insighta, a landmark venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Backed by world-class science from Prof. Lo, robust capital resources of US$100m from Prenetics, and led by successful entrepreneur Danny Yeung, the venture is poised to transform cancer screening. Insighta presents an unprecedented opportunity to save lives and bolster Hong Kong's standing as a global hub for life sciences innovation.

Treatment

With the acquisition of ACT Genomics, we can now offer comprehensive
cancer treatments worldwide, bringing us closer to our goal of detecting
and treating cancer as early as possible.
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’.